Study Acronym | Study Name | Country |
---|---|---|
ACBRCA | ACCamargo BRCA Mutation Carriers | Brazil |
BCFR-AU | Australian site of the Breast Cancer Family Registry | Australia |
BCFR-NC | Northern California site of the Breast Cancer Family Registry | USA |
BCFR-NY | New York site of the Breast Cancer Family Registry | USA |
BCFR-ON/OCGN | Ontario site of the Breast Cancer Family Registry/Ontario Cancer Genetics Network | Canada |
BCFR-PA | Philadelphia site of the Breast Cancer Family Registry | USA |
BCFR-UT | Utah site of the Breast Cancer Family Registry | USA |
BCS-UAB | Breast Cancer Study Ukraine Association of Biobank | Ukraine |
BFBOCC-LT | Baltic Familial Breast Ovarian Cancer Consortium - Lithuania | Lithuania |
BFBOCC-LV | Baltic Familial Breast Ovarian Cancer Consortium - Latvia | Latvia |
BIDMC | Beth Israel Deaconess Medical Center | USA |
BMBSA | BRCA-gene mutations and breast cancer in South African women | South Africa |
BRICOH | Beckman Research Institute of the City of Hope | USA |
CBCS | Copenhagen Breast Cancer Study | Denmark |
CCGCRN | Clinical Cancer Genomics Community Research Network | USA |
CEMIC | CEMIC-Breast Cancer Genes Variants in South America | Argentina |
CFBCS | Cyprus Familial Breast Cancer Study | Cyprus |
CNIO | Spanish National Cancer Centre | Spain |
CONSIT TEAM | CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella | Italy |
CTCR-BRCA | Centre for Translational Cancer Research-Breast Cancer Cohort | India |
CZ-BRCA | Czech BRCA Study | Czech Republic |
CZECANCA | CZEch CAncer paNel for Clinical Application | Czech Republic |
DEMOKRITOS | National Centre for Scientific Research Demokritos | Greece |
DFCI | Dana Farber Cancer Institute | USA |
DKFZ | German Cancer Research Center | Germany/Pakistan/Colombia |
EMBRACE | Epidemiological Study of Familial Breast Cancer | UK |
FCCC | Fox Chase Cancer Center | USA |
FIMR | Feinstein Institute for Medical Research | USA |
FPGMX | Fundación Pública Galega de Medicina Xenómica | Spain |
G-FAST | Ghent University Hospital | Belgium |
GC-HBOC | German Consortium of Hereditary Breast and Ovarian Cancer | Germany |
GEMO | Genetic Modifiers of cancer risk in BRCA1/2 mutation carriers | France/USA |
GEORGETOWN | Georgetown University | USA |
GIIS025 | Oncología Médica Hospital Clínico Universitario Lozano Blesa | Spain |
HCBARRETOS | BRCA1 and BRCA2 mutations in a Brazilian population sample at risk for hereditary breast and ovarian cancer | Brazil |
HCSC | Hospital Clinico San Carlos | Spain |
HEBCS | Helsinki Breast Cancer Study | Finland |
HEBON | Hereditary Breast and Ovarian cancer study the Netherlands | Netherlands |
HRBCP | Study of Genetic Mutations in Breast and Ovarian Cancer patients in Hong Kong and Asia | Hong Kong |
HUNBOCS | Molecular Genetic Studies of Breast- and Ovarian Cancer in Hungary | Hungary |
HVH | University Hospital Vall d'Hebron | Spain |
ICARE | Inherited Cancer Registry | USA |
ICO | Institut Català d'Oncologia | Spain |
IFBCRC | Iranian Familial Breast Cancer Registry Consortium | Iran |
IHCC | International Hereditary Cancer Centre | Poland |
ILUH | Iceland Landspitali - University Hospital | Iceland |
INHERIT | INterdisciplinary HEalth Research Internal Team BReast CAncer susceptibility | Canada (Quebec) |
IOVHBOCS | Istituto Oncologico Veneto | Italy |
IPOBCS | Portuguese Oncology Institute-Porto Breast Cancer Study | Portugal |
KCONFAB | Kathleen Cuningham Consortium for Research into Familial Breast Cancer | Australia |
KOHBRA | Korean Hereditary Breast Cancer Study | Korea |
KUMC | University of Kansas Medical Center | USA |
MACBRCA | Macedonian BRCA Mutation Carriers | Republic of Macedonia |
MAGIC | Modifiers and Genetics in Cancer | USA |
MAYO | Mayo Clinic | USA |
MCGILL | McGill University | Canada (Quebec) |
MSKCC | Memorial Sloane Kettering Cancer Center | USA |
MUV | General Hospital Vienna | Austria |
MYBRCA | Malaysian Breast Cancer Genetic Study | Malaysia |
NAROD | Women's College Research Institute Hereditary Breast and Ovarian Cancer Study | Canada |
NCCS | National Cancer Centre Singapore | Singapore |
NCI | National Cancer Institute | USA |
NLBR | Newfoundland BRCA Study | Canada |
NNPIO | N.N. Petrov Institute of Oncology | Russia |
NORTHSHORE | NorthShore University HealthSystem | USA |
NRG_ONCOLOGY | NRG Oncology | USA/Australia |
NZFBCS | New Zealand Familial Breast Cancer Study | New Zealand |
OBRCA | Oslo BRCA1/2 | Norway/Peru |
OSU CCG | The Ohio State University Comprehensive Cancer Center | USA |
OUH | Odense University Hospital | Denmark |
PBCS | Università di Pisa | Italy |
PUR BCGG | Puerto Rico Breast Cancer Genetics & Genomics study | Puerto Rico |
RSUIO | Riga Stradins University Institute of Oncology | Latvia |
SGBCC | Singapore Breast Cancer Genetic Study | Singapore |
SMC | Sheba Medical Center | Israel |
SWE-BRCA | Swedish Breast Cancer Study | Sweden |
TBCC | Taiwan Hereditary Breast Cancer Consortium | Taiwan |
UCHICAGO | University of Chicago | USA |
UCLA | University of California Los Angeles | USA |
UCSF | University of California San Francisco | USA |
UIL | University of Illinois | USA |
UKGRFOCR | UK and Gilda Radner Familial Ovarian Cancer Registries | UK/USA |
UNIFI | University of Florence | Italy |
UPENN | University of Pennsylvania | USA |
UPITT | Cancer Family Registry University of Pittsburg | USA |
UTMDACC | University of Texas MD Anderson Cancer Center | USA |
VFCTG | Victorian Familial Cancer Trials Group | Australia |
WCP | Women's Cancer Program at Cedars-Sinai Medical Center | USA |